ATXI
AVENUE THERAPEUTICS, INC.
-0.02 (-3.19%)0.55USD3.3K成交股數1.8M市值4.2本益比(近四季)–股價營收比-100.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0-100% | – | – | 0 | 1.4M | – | 0 | 0 | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 247K | 200K | 257K | 177K | 192K | 411K | 2.3M | 1.4M | 2.4M | 982K | 907K | 3.0M |
| 銷售管理費用 | 460K | 514K | 697K | 547K | 915K | 1.5M | 829K | 1.5M | 1.3M | 1.1M | 1.2M | 896K |
| 營業利益 | −707K-338% | −714K-63% | −751K-76% | −724K-74% | 297K-108% | −1.9M-10% | −3.2M+53% | −2.8M-28% | −3.7M | −2.1M | −2.1M | −3.9M |
| 營業利益率 | – | – | – | – | 21.2% | – | – | – | – | – | – | – |
| 稅後淨利 | −690K-306% | −695K-62% | −709K-77% | −683K-75% | 335K-108% | −1.9M-411% | −3.1M-685% | −2.7M-33% | −4.3M | 595K | 526K | −4.0M |
| 淨利率 | – | – | – | – | 23.9% | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | 0.06 | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | 8.2M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.9M | 2.4M | 2.9M | 3.7M | 3.3M | 3.5M | 2.6M | 4.9M | 3.2M | 1.8M | 161K | 1.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 2.0M | 2.5M | 2.9M | 3.7M | 4.2M | 3.6M | 2.6M | 5.0M | 3.3M | 1.9M | 502K | 1.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.4M | 1.3M | 1.1M | 1.4M | 1.3M | 1.3M | 973K | 1.2M | 1.4M | 1.2M | 5.0M | 7.8M |
| 股東權益 | 569K | 1.2M | 1.8M | 3.6M | 4.1M | 3.5M | 2.6M | 4.8M | 2.8M | 1.6M | −3.7M | −5.3M |
| 負債比 | 71.2% | 51.5% | 37.5% | 38.2% | 31.9% | 35.1% | 37.1% | 23.3% | 42.7% | 64.6% | 1,000.8% | 468.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −438K-63% | – | – | – | −1.2M | – | – | −3.1M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.4M | – | −2.9M | -207.2% | – | – |
| FY2024 | 0 | – | −11.7M | –% | – | – |
| FY2023 | – | – | −10.5M | –% | – | – |
| FY2022 | – | – | −3.6M | –% | – | – |
| FY2021 | – | – | −3.7M | –% | -0.22 | – |
| FY2020 | – | – | −5.2M | –% | -0.31 | – |
| FY2019 | – | – | −25.9M | –% | -1.65 | – |
| FY2018 | – | – | −21.5M | –% | -2.10 | – |